1) Invasive bladder cancer
浸润性膀胱癌
1.
The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer;
保留膀胱手术联合动脉化疗治疗浸润性膀胱癌的临床研究
2.
The golden standard for the treatment of invasive bladder cancer is radical cystectomy,but for the dangerous of progressivity and metastasis, Up to 50 % of these patients may die of distant metastasis.
膀胱癌根治术是治疗浸润性膀胱癌的首选治疗方法,但大多数浸润性膀胱癌是高分级的,具有局部进展和远处转移的危险,超过50%的浸润性膀胱癌患者死于远处转移。
2) superficial bladder cancer
非肌层浸润性膀胱癌
1.
Clinical observation of differrent fiber holmium laser in the therapy of superficial bladder cancer
不同光纤钬激光治疗非肌层浸润性膀胱癌的临床观察
3) superficial bladder cancer
浅表性膀胱癌
1.
Photoselective vaporization for the treatment of superficial bladder cancer;
光选择性汽化术治疗浅表性膀胱癌
2.
Transurethral resection remains the Standard for first-line treatment, but patients with superficial bladder cancer are at such high risk for recurrence that a variety of treatments have been employed as adjuvant therapy to prevent the recurrence and progression of the cancer.
浅表性膀胱癌(T_1,Ta,Tis)术后易复发,尽管大多数复发的肿瘤与原发肿瘤的分级、分期相同,但5％—30％的肿瘤发展向深层浸润。
4) bladder transitional cell cancer
膀胱移性细胞癌
1.
MCM2 expression in bladder transitional cell cancer and its prognostic significance;
MCM2在膀胱移性细胞癌的表达及其预后意义
5) Malignant carcinoid tumor of the urinary bladder
膀胱恶性类癌
6) bladder cancer
膀胱癌
1.
The Clinical Application of Urine Fibronectin Detection in the Patients with Bladder Cancer.;
尿纤维连接蛋白检测在膀胱癌患者中的临床应用
2.
Detection of hTERT mRNA expression in urine exfoliated cells and its significance in diagnosing bladder cancer and monitoring recurrence;
尿脱落细胞端粒酶催化亚基mRNA检测在膀胱癌诊断和监测复发中的意义
3.
siRNA inhibits vegf expression in bladder cancer;
利用siRNA沉默VEGF对膀胱癌生长的影响
补充资料：膀胱浸润性癌
膀胱浸润性癌
infiltrating carcinoma of bladder
又称“实体性癌”。恶性度高，无乳头，表面不平，有显著坏死及钙盐沉着，溃疡边缘呈结节状，早期向深处浸润，转移较早。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条